What is CVE-2022-38803?

CVE-2022-38803 is a medium-severity vulnerability in Zkteco Biotime, classified under Cross-site Scripting. CVSS score: 6.8/10. Published 2022-11-30.

How severe is CVE-2022-38803?

Medium severity. CVSS v3 base score is 6.8 out of 10.

XSS in Zkteco Biotime

CVE-2022-38803

Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via Leave, overtime, Manual log. An authenticated employee can read local files by exploiting XSS into a pdf generator when exporting data as a PDF

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.006 (46.0th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.8 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:N/A:N.

Affected products

Zkteco Biotime
N/a — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cve@mitre.org (Product)
cve@mitre.org (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2022-38803?: CVE-2022-38803 is a medium-severity vulnerability in Zkteco Biotime, classified under Cross-site Scripting. CVSS score: 6.8/10. Published 2022-11-30.
How severe is CVE-2022-38803?: Medium severity. CVSS v3 base score is 6.8 out of 10.